Background illustration for clinical trials search

Paid Clinical Trials Arizona

Discover 1,569 paid clinical trials in Arizona. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients

for
Localized Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8,
Location: Jacksonville FL, Scottsdale AZ
Sponsor: Mayo Clinic

Sex: Male

Age: 18+

Code: NCT05045066

Early_phase1, Recruiting

A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma

for
Primary Open Angle Glaucoma
Location: Phoenix AZ, Newport Beach CA, Glendale CA
Sponsor: Amydis Inc.

Sex: All

Age: 22+

Code: NCT06223048

Phase2, Recruiting

Registry Study for Radiation Therapy Outcomes

for
Neoplasms
Location: New York NY, Somerset NJ, Hampton VA, Baltimore MD,
Sponsor: Proton Collaborative Group

Sex: All

Age: 0+

Code: NCT01255748

Recruiting

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, New Haven CT, Miami FL, Charleston SC,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06253130

Phase1, Phase2, Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Providence RI, Farmington CT, New Haven CT, Lebanon NH,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05552222

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for
Superficial Bladder Cancer,
Location: Halifax, Boston MA, New Haven NY, Albany NY,
Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase1, Phase2, Recruiting

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Boston MA, Burlington MA, Hartford CT, Springfield MA,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female

Age: 18+

Code: NCT05128825

Phase2, Recruiting

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

for
Prostate Cancer, Prostatic Neoplasms
Location: New York NY, Albany NY, Myrtle Beach SC, Durham NC,
Sponsor: Clarity Pharmaceuticals Ltd

Sex: Male

Age: 18+

Code: NCT06056830

Phase3, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase3, Recruiting

ORB-021 In Patients With Advanced Solid Tumors

for
Advanced Solid Tumors Cancer
Location: Houston TX, Scottsdale AZ
Sponsor: Orionis Biosciences Inc

Sex: All

Age: 18+

Code: NCT06607939

Phase1, Recruiting

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

for
Type 2 Diabetes
Location: New Haven CT, Hyde Park NY, Philadelphia PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 10 - 17

Code: NCT06739122

Phase3, Recruiting

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

for
Endometrial Cancer, Cervical Cancer,
Location: Westbury NY, Howard Beach NY, Richmond VA, Miami FL,
Sponsor: Mayo Clinic

Sex: Female

Age: 18+

Code: NCT05051722

Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

for
Hematologic Malignancies
Location: Boston MA, Chapel Hill NC, Tampa FL, Greenville SC,
Sponsor: Sellas Life Sciences Group

Sex: All

Age: 12+

Code: NCT04588922

Phase1, Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

for
Systemic Lupus Erythematosus
Location: Rimouski, Quebec, Manhasset NY, New York NY,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 16+

Code: NCT06617325

Phase3, Recruiting

A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)

for
Septic Shock, Sepsis, Hypovolemia
Location: Winston-Salem NC, Savannah GA, Kansas City MO,
Sponsor: Vivacelle Bio

Sex: All

Age: 18+

Code: NCT06072430

Phase3, Recruiting

MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial

for
Sepsis, Low Blood Pressure
Location: Jacksonville FL, Eau Claire WI, Rochester MN,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06319248

Phase2, Recruiting

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

for
Geographic Atrophy, Macular Degeneration
Location: Portland ME, Boston MA, Norfolk VA, Baltimore MD,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 60+

Code: NCT06635148

Phase2, Phase3, Recruiting

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

for
Chronic Myeloid Leukemia, Chronic Phase,
Location: New York NY, Philadelphia PA, Winston-Salem NC,
Sponsor: Terns, Inc.

Sex: All

Age: 18+

Code: NCT06163430

Phase1, Phase2, Recruiting

SportsPro: Post-Market Clinical Follow Up Study

for
Shoulder Injuries, Knee Injuries, Hip Injuries
Location: San Antonio TX, Englewood CO, Phoenix AZ
Sponsor: Stryker Endoscopy

Sex: All

Age: 18+

Code: NCT06320925

Recruiting

Observational, Non-Interventional Study Supporting Validation of eVO2peak Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)

for
Cardiopulmonary
Location: St. John's, Wilmington DE, Hollywood FL,
Sponsor: Prolaio

Sex: All

Age: 18+

Code: NCT05678530

Recruiting

Popular cities in Arizona

With a diverse healthcare network and renowned medical research institutions, Arizona is a key player in clinical research. Leading clinical research organizations such as the Mayo Clinic in Phoenix, Banner Health, University of Arizona Health Sciences, and the Translational Genomics Research Institute (TGen) are driving medical research and innovation advancements. These institutions are at the forefront of clinical studies, contributing significantly to cutting-edge treatments and healthcare advancements across the state.

Why choose Arizona for clinical trials?

Participating in clinical trials in Arizona offers several unique advantages. First, due to the state being home to some of the nation's top research institutions, participants have access to cutting-edge treatments and advanced medical care. These institutions are leaders in fields like oncology, cardiology, and precision medicine, allowing participants to be at the forefront of groundbreaking medical advancements.

Another significant advantage is Arizona's diverse population, which allows for a broad range of clinical trials addressing different demographics and health conditions. This diversity increases the relevance of clinical trial outcomes across varied populations, ensuring more accurate and inclusive medical research. Additionally, Arizona’s pleasant climate and growing healthcare infrastructure make participation in trials more convenient and accessible, especially for those traveling to Phoenix or Tucson for care.

Common conditions studied in Arizona

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Arizona